Achalasia–Microcephaly Syndrome (AMS)

Achalasia–microcephaly syndrome (AMS) is an extremely rare genetic disorder in which a child has both achalasia (the food pipe does not relax and push food into the stomach) and microcephaly (a smaller-than-expected head size with brain growth problems). Only a handful of families and isolated cases have been reported in the medical literature since the first description in 1978. Because it is so rare, doctors often recognize it by its pattern: feeding and swallowing problems from achalasia together with a small head size and developmental delay from microcephaly. orpha.netNCBILippincott Journals

Achalasia–microcephaly syndrome (AMS) is a very rare genetic condition. Children have two main problems:

• Microcephaly: the head and brain are smaller than expected, which can cause developmental delay and learning problems.

• Achalasia: the lower end of the food pipe (esophagus) does not open properly, so food and drink do not pass easily into the stomach. This leads to choking, coughing, vomiting, chest discomfort after eating, poor weight gain, and chest infections from aspiration (food or liquid going into the lungs).

Symptoms usually start in infancy or early childhood. Only a small number of families around the world have been reported. In several reports, the affected children were born to related (consanguineous) parents, suggesting autosomal recessive inheritance (a child needs two changed copies of the gene, one from each parent). A single report mentioned mefloquine exposure in pregnancy in one simplex case; this is an observation and not proven causation. Because the condition is so rare, the exact gene(s) are not firmly established in the public literature, and treatment focuses on symptoms and supportive care. Genetic & Rare Diseases CenterNCBIorpha.netPubMedWiley Online Library

---

Other names

• Achalasia–microcephaly syndrome (AMS) — the most common name in journals and rare-disease catalogs. orpha.net

• Familial achalasia with microcephaly and intellectual disability — highlights that several reports occurred in siblings born to related parents. SAGE JournalsWiley Online Library

• OMIM #200450 entity — how the syndrome is indexed in genetics references (based on case-report literature). Lippincott Journals

AMS is not the same as Allgrove (Triple-A) syndrome, which combines achalasia with alacrima (reduced tears) and adrenal insufficiency. Some people with Allgrove can also have microcephaly, which can cause confusion, but Allgrove is a different, better-understood condition caused by AAAS (ALADIN) gene variants. MedlinePlusMedscapeLippincott Journals

Achalasia–microcephaly syndrome is a genetic condition that shows up early in life. The esophagus (food pipe) fails to move food down and the lower esophageal sphincter does not relax well. This leads to trouble swallowing, choking, vomiting, coughing after feeds, and poor weight gain. At the same time, the head size is small for age because the brain does not grow normally. Many children have developmental delay and later learning difficulties. The combination can cause recurrent chest infections from food or liquid going into the airway, and failure to thrive. Because AMS is so rare, doctors often diagnose it by putting together the clinical picture and ruling out more common causes. orpha.netNCBI

• The syndrome was first reported in 1978 in several siblings from a Mexican family. Since then, additional cases have been described from different countries, often in children of consanguineous parents (parents who are related), which suggests autosomal recessive inheritance. Lippincott JournalsWiley Online LibrarySAGE Journals

• By 2017, only a handful of patients had been published worldwide, underlining just how rare AMS is. accesspediatrics.mhmedical.comWikipedia

• One case report mentioned maternal mefloquine exposure very early in pregnancy; this association is not proven but is noted in the literature. PubMed

---

Types

There are no official molecular sub-types yet because the exact gene(s) responsible remain unclear. Clinicians sometimes find it useful to think in clinical patterns:

1. Classic familial AMS
   Children from the same family, usually with consanguinity, share achalasia plus microcephaly and some degree of intellectual disability. This pattern suggests autosomal recessive inheritance. SAGE JournalsWiley Online Library

2. Sporadic AMS
   A single affected child with the same core features and no family history. A few such cases have been reported. PubMed

3. AMS-like picture where Allgrove is excluded
   The child has achalasia and microcephaly, without alacrima or adrenal problems, and testing does not show the AAAS gene changes seen in Allgrove syndrome. This helps avoid mislabeling. Lippincott Journals

These patterns are practical, not official classifications, and they mainly help doctors organize testing and counseling.

---

Causes or contributing factors

Because AMS is so rare, the main cause is believed to be genetic, very likely autosomal recessive. Other items below describe mechanisms or contexts reported around cases, plus important differentials doctors consider and exclude when diagnosing AMS.

1. Autosomal recessive gene changes (unknown gene)
   Multiple sibling cases in consanguineous families point to a recessive inheritance, even though a single causative gene has not been pinned down yet. SAGE JournalsWiley Online Library

2. Enteric nervous system dysfunction of the esophagus
   In achalasia, nerves in the myenteric (Auerbach) plexus degenerate or fail to develop correctly, so the lower esophageal sphincter does not relax. In AMS, this mechanism likely contributes to swallowing symptoms. (General achalasia pathophysiology applied to this syndrome.) orpha.net

3. Early brain growth disturbance
   Primary microcephaly results from reduced brain growth during fetal life or early infancy, which explains the small head size and developmental challenges. NCBI

4. Consanguinity (parental relatedness)
   Many reported AMS families involved consanguineous parents, increasing the chance that both parents carry the same rare recessive variant. SAGE Journals

5. Sporadic (de novo) variants
   A child can have a new (“de novo”) variant not present in either parent; this is plausible in sporadic AMS reports. (General genetics principle, reflected in GARD rare-disease overview.) Genetic & Rare Diseases Center

6. Gene-environment interaction (rare/uncertain)
   A report mentioned mefloquine exposure in early pregnancy; while this does not prove causation, it raises the possibility of environmental modification of risk. PubMed

7. Secondary malnutrition worsening microcephaly
   Severe feeding difficulty from achalasia can aggravate poor growth, which may further limit head growth and development. (Inference aligned with clinical descriptions.) NCBI

8. Recurrent aspiration and lung illness
   Repeated chest infections from misdirected feeds can sap nutrition and oxygen, compounding developmental problems. (Syndrome definition mentions aspiration in infancy.) NCBI

9. Delayed recognition of achalasia
   Late diagnosis can prolong under-nutrition and respiratory complications, indirectly worsening neurodevelopmental outcomes. (General clinical principle in rare achalasia of infancy.) orpha.net

10. Overlap ruled out: Allgrove (Triple-A) syndrome
    Allgrove can feature achalasia and sometimes microcephaly, but it adds alacrima and adrenal insufficiency and has a known AAAS gene cause; it is a key differential, not a cause of AMS. MedlinePlusLippincott Journals

11. Other genetic microcephalies (differentials)
    Many genetic conditions cause microcephaly (without achalasia). Doctors rule these out using genetic panels or exome sequencing. (General GARD genetics guidance.) Genetic & Rare Diseases Center

12. Chromosomal copy-number changes (differentials)
    Microdeletions or microduplications may cause microcephaly; testing helps exclude these when AMS is suspected. (General genetics practice per rare-disease guidance.) Genetic & Rare Diseases Center

13. Prenatal infections (differentials)
    Some infections can cause microcephaly, but they do not explain achalasia. Testing helps distinguish these from AMS. (General clinical differentiation.) NCBI

14. Perinatal hypoxic injury (differential)
    Lack of oxygen around birth can cause microcephaly over time; again, this does not cause achalasia, so clinicians separate it from AMS. (General neurology principle.) NCBI

15. Metabolic disorders (differentials)
    Inborn errors can reduce brain growth; metabolic screening helps rule these out in a child with microcephaly plus swallowing problems. (General practice in developmental evaluation.) NCBI

16. Structural brain malformations (co-occurring or differential)
    Brain imaging may show simplified gyri or other abnormalities explaining developmental delays; these findings help profile microcephaly but are not proven causes of AMS. (General microcephaly workup.) NCBI

17. Autoimmune injury (unlikely in classic AMS)
    Autoimmune damage to enteric neurons is discussed in adult achalasia but has not been shown to cause AMS; clinicians still consider it when adults present with achalasia alone. (Context from broader achalasia literature.) orpha.net

18. Mitochondrial disease (differential)
    Mitochondrial disorders can cause neurodevelopmental issues and dysphagia but do not explain the very specific achalasia pattern; genetics helps exclude them. (General differential principle.) Genetic & Rare Diseases Center

19. Syndromic esophageal dysmotility from other genes (differentials)
    Conditions like Allgrove (AAAS) or other neurocristopathies may mimic aspects of AMS; targeted panels help distinguish them. Lippincott Journals

20. Idiopathic (cause not found despite testing)
    Given the rarity, some cases will remain unexplained even after extensive genetic workup; the clinical pattern still guides care. (Reality acknowledged in rare-disease summaries.) orpha.net

---

Common signs and symptoms

1. Feeding difficulty in infancy
   Babies cough, choke, or take a very long time to feed because food stalls in the esophagus. Parents may see back-arching or distress during feeds. NCBI

2. Dysphagia (trouble swallowing)
   Both liquids and solids can be hard to swallow. In infants this shows as gagging or regurgitation; in older children, they may avoid certain textures. orpha.net

3. Regurgitation and vomiting
   Food may come back up undigested, especially when lying down, because the esophagus does not push it into the stomach. NCBI

4. Coughing during or after feeds
   This suggests food or liquid is going toward the airway (aspiration). Repeated episodes can lead to chest infections. orpha.net

5. Recurrent chest infections / aspiration pneumonia
   Inhaled feeds inflame the lungs, causing fever, cough, and breathing trouble. Preventing aspiration is a priority. NCBI

6. Failure to thrive / poor weight gain
   Children may not gain weight or height as expected because swallowing is hard and they burn energy coping with feeds. orpha.net

7. Irritability and disturbed sleep
   Discomfort from retained food and coughing at night can disrupt sleep and cause irritability. NCBI

8. Microcephaly (small head circumference)
   Head size measures below the expected percentile for age and sex. This is a defining feature of AMS. orpha.net

9. Global developmental delay
   Delays in sitting, walking, and speaking may appear in infancy and early childhood. NCBI

10. Learning difficulties / intellectual disability
    School-age children may need special education support. Severity varies among reported cases. orpha.net

11. Speech and language delay
    Understanding may be ahead of expression; therapy helps maximize communication. NCBI

12. Hypotonia or abnormal muscle tone
    Some infants feel “floppy,” while others may show increased tone; both reflect underlying neurodevelopmental involvement. NCBI

13. Feeding aversion and food selectivity
    Children may prefer liquids or soft foods; they may eat slowly or pocket food in the mouth to avoid choking. orpha.net

14. Respiratory wheeze or noisy breathing
    Irritation from aspiration can cause wheeze, especially during viral illnesses. NCBI

15. Dehydration episodes
    Vomiting and poor intake can lead to reduced urine output and lethargy; prompt fluids are important. orpha.net

---

Diagnostic tests

A) Physical examination (bedside assessment)

1. Head-circumference measurement
   The clinician measures head size and plots it on standardized growth charts. Microcephaly is defined by head circumference below set percentile or standard deviations for age and sex. This confirms a key component of AMS. NCBI

2. Weight, length/height, and BMI
   Growth tracking shows failure to thrive if weight and length fall behind expected curves, guiding nutrition plans. orpha.net

3. Feeding observation
   Watching a feed helps identify coughing, gagging, regurgitation, prolonged feeding, and distress—features that raise suspicion for achalasia. NCBI

4. Respiratory exam
   Listening to the chest may reveal crackles or wheeze suggesting aspiration or infection. Oxygen level checks can show severity. orpha.net

5. Neurological exam and developmental screening
   Tone, reflexes, cranial nerves, and age-appropriate milestones are assessed to profile the neurodevelopmental component. NCBI

B) Manual or bedside functional tests

6. Bedside swallow assessment by a speech-language therapist
   A structured assessment of oral motor control, chewing, and safe swallowing helps plan textures and strategies to reduce aspiration risk. NCBI

7. Gag reflex and cranial nerve testing
   Simple checks of palate movement, voice quality, and cough strength can uncover bulbar dysfunction related to swallowing safety. NCBI

8. Rapid water swallow test (clinical screening)
   Carefully supervised sips of water can reveal cough, voice changes, or residue, prompting instrumental studies for achalasia and aspiration. (A standard clinical screen feeding into formal testing.) orpha.net

9. Developmental tools (e.g., standardized milestone checklists)
   Practical checklists help quantify delays and guide early-intervention referrals. NCBI

C) Laboratory and pathological tests

10. Complete blood count (CBC)
    Looks for infection (aspiration pneumonia) and anemia from poor intake. Results guide treatment urgency. NCBI

11. Electrolytes, kidney and liver function
    Vomiting and low intake can cause dehydration and electrolyte imbalance; labs help correct fluids safely. orpha.net

12. Inflammatory markers (CRP/ESR)
    Elevated levels support a diagnosis of infection during chest illness episodes related to aspiration. NCBI

13. Genetic testing: chromosomal microarray
    Screens for copy-number changes that could cause microcephaly; a normal result encourages exome sequencing next. Genetic & Rare Diseases Center

14. Genetic testing: clinical exome or genome sequencing
    Searches for rare, recessive variants in genes tied to esophageal motility and brain development. Results guide counseling even if a specific “AMS gene” is not yet established. Genetic & Rare Diseases Center

15. Infection screen when relevant (e.g., TORCH)
    Helps exclude congenital infections that can cause microcephaly without achalasia. NCBI

16. Endoscopic biopsies (selected cases)
    During upper endoscopy, biopsies can exclude inflammation or eosinophilic esophagitis that might mimic achalasia symptoms. (General achalasia workup context.) orpha.net

D) Electrodiagnostic / physiologic studies

17. High-resolution esophageal manometry (HRM)
    The key test for achalasia. A thin catheter measures pressure in the esophagus and lower sphincter. It shows failure of relaxation and poor peristalsis, confirming the motility disorder. orpha.net

18. pH-impedance monitoring (selected cases)
    Measures reflux and how fluid or food moves in the esophagus; helps separate reflux from achalasia-related stasis and aspiration risk. (Standard pediatric motility evaluation principle.) orpha.net

19. Electroencephalography (EEG) if seizures are suspected
    Some children with microcephaly can have seizures; EEG helps detect and guide treatment. (General microcephaly care.) NCBI

E) Imaging tests

20. Barium swallow (contrast esophagram)
    X-ray images taken while drinking contrast show a dilated esophagus narrowing to a classic “bird-beak” at the lower sphincter—strong evidence of achalasia. orpha.net

21. Upper endoscopy (EGD)
    A camera test that looks for retained food and rules out mechanical blockage; it also evaluates for inflammation and allows dilation in some cases. orpha.net

22. Chest X-ray
    May show a wide, air-fluid level in the esophagus and signs of aspiration or pneumonia. NCBI

23. Brain MRI
    Gives a detailed picture of brain growth and structure in microcephaly; helps identify patterns that support a genetic cause. NCBI

24. Head ultrasound (infants)
    A bedside, radiation-free look at brain size and ventricles in very young infants while the fontanelle is open. NCBI

25. CT (when MRI is not possible)
    Offers a quick survey of brain structure and head size if MRI cannot be done, balancing the need against radiation exposure. NCBI

Non-pharmacological treatments

(includes ~15 physiotherapy-type strategies, plus mind–body supports and educational therapy; each with description, purpose, mechanism, benefits)

Important: These supports are individualized by your child’s care team (pediatrician, gastroenterologist, neurologist, speech-language pathologist, dietitian, physiotherapist/occupational therapist). They work best together.

1. Feeding and swallowing therapy (SLP-led)
   Purpose: make swallowing safer and more efficient.
   Mechanism: exercises for oral-motor control; pacing and postural techniques; texture trials; safe-swallow strategies.
   Benefits: fewer choking events, better nutrition, less aspiration.

2. Texture modification of foods
   Purpose: reduce blockage at the tight sphincter and lower aspiration risk.
   Mechanism: start with pureed/soft solids; progress as tolerated; avoid dry, sticky foods.
   Benefits: easier passage, less regurgitation.

3. Thickened liquids (when SLP recommends)
   Purpose: slow liquid flow to match swallow timing.
   Mechanism: commercial thickeners or starch/gum based agents to target Nectar/Honey thickness.
   Benefits: lowers aspiration in children who aspirate thin liquids.

4. Small, frequent, high-calorie meals
   Purpose: maintain growth without overwhelming the esophagus.
   Mechanism: 5–6 energy-dense feeds/day; add healthy fats/powders per dietitian plan.
   Benefits: better weight gain, less post-meal chest pressure.

5. Upright feeding posture and 30–45 minutes upright after meals
   Purpose: gravity assistance and reflux control.
   Mechanism: seated upright, chin-tuck as taught by SLP.
   Benefits: fewer coughs, less regurgitation.

6. Reflux precautions
   Purpose: reduce acid exposure and aspiration.
   Mechanism: avoid late heavy meals; elevate head of bed; burp breaks.
   Benefits: less heartburn and night cough.

7. Chest physiotherapy (as taught)
   Purpose: clear airway secretions after aspiration episodes or infections.
   Mechanism: percussion, postural drainage, breathing exercises.
   Benefits: fewer pneumonias, faster recovery.

8. Physiotherapy for gross-motor development
   Purpose: build strength, balance, and posture delayed by neurologic impairment.
   Mechanism: task-oriented play, stretching of tight muscle groups, gait work.
   Benefits: better mobility and endurance.

9. Occupational therapy (OT)
   Purpose: improve hand skills, daily living tasks, and feeding independence.
   Mechanism: fine-motor training, adaptive utensils/cups, seating devices.
   Benefits: more participation at home and school.

10. Speech-language therapy for communication
    Purpose: improve speech or provide alternatives if speech is limited.
    Mechanism: articulation training; AAC (picture boards, tablets) when needed.
    Benefits: reduces frustration; improves learning and social connection.

11. Individualized Education Program (IEP) / special education
    Purpose: match teaching to the child’s cognitive profile.
    Mechanism: simple language, repetition, visual supports, extra time.
    Benefits: better school progress and behavior.

12. Behavioral therapy / parent training
    Purpose: manage feeding anxiety, medical trauma, or behavior linked to delays.
    Mechanism: positive reinforcement, gradual exposure, routines.
    Benefits: calmer mealtimes; more cooperation with care.

13. Caregiver mental-health and stress supports (mind–body)
    Purpose: sustain family wellbeing.
    Mechanism: counseling, mindfulness, breathing exercises, support groups.
    Benefits: lower caregiver burnout; better adherence to care plans.

14. Sleep hygiene program
    Purpose: improve sleep quality, which supports growth and learning.
    Mechanism: fixed bedtime, dark quiet room, reflux-safe positioning.
    Benefits: better daytime focus; fewer night symptoms.

15. Vision and hearing services
    Purpose: optimize sensory input for learning and safety.
    Mechanism: screening; glasses/hearing aids; classroom accommodations.
    Benefits: improved communication and development.

16. Aspiration-risk action plan
    Purpose: early response to cough, fever, or breathing trouble.
    Mechanism: watch-and-act checklist; when to seek urgent care.
    Benefits: prevents severe pneumonia.

17. Dental/oral care program
    Purpose: reduce caries and aspiration of oral bacteria.
    Mechanism: assisted brushing, fluoride, dental visits.
    Benefits: fewer infections; better comfort.

18. Immunization on schedule
    Purpose: prevent respiratory infections that worsen feeding problems.
    Mechanism: routine vaccines, including flu and pneumococcal per national schedule.
    Benefits: fewer hospitalizations.

19. Nutrition therapy (dietitian-led)
    Purpose: meet energy/micronutrient needs despite limited intake.
    Mechanism: calorie boosters, modular formulas, monitored growth charts.
    Benefits: improved weight, immunity, wound healing.

20. Safe-medication review
    Purpose: avoid drugs that relax LES too much or worsen swallow safety without benefit.
    Mechanism: pharmacist review of all prescriptions and OTCs.
    Benefits: fewer side effects and interactions.

21. Augmented hydration routines
    Purpose: prevent dehydration from vomiting/regurgitation.
    Mechanism: frequent sips, oral rehydration solutions during illness.
    Benefits: stable energy and safer procedures.

22. Gastrostomy tube (G-tube) feeding plan (if needed)
    Purpose: reliable nutrition/medication route when oral feeding is unsafe.
    Mechanism: partial or complete G-tube feeds; continue oral tastes if safe.
    Benefits: growth, less aspiration, reduced feeding stress.

23. School feeding and swallowing plan
    Purpose: keep mealtimes safe at school.
    Mechanism: trained staff, approved textures, supervised drinking.
    Benefits: consistency and safety outside home.

24. Care coordination
    Purpose: align multiple specialists’ plans.
    Mechanism: case manager or nurse coordinator; shared care plan.
    Benefits: fewer conflicting instructions; smoother care.

25. Emergency information kit
    Purpose: fast, accurate care in emergencies.
    Mechanism: diagnosis summary, usual meds, last procedures, contact list.
    Benefits: quicker, safer decisions in the ER.

---

Drug treatments

Speak with your child’s specialists before any medicine. Doses below are typical pediatric/teen ranges; exact dosing depends on age, weight, and local guidelines.

1. Nifedipine (calcium-channel blocker, sublingual before meals)
   Purpose: relax the lower esophageal sphincter (LES) to ease swallowing.
   Typical dose: 0.25–0.5 mg/kg (max single 10 mg) 15–30 min before meals.
   Mechanism: smooth-muscle relaxation → lower LES pressure.
   Side effects: low blood pressure, flushing, dizziness, headache.

2. Isosorbide dinitrate (nitrate, before meals)
   Purpose: short-term LES relaxation.
   Typical dose: 2.5–5 mg in older children/teens before meals (specialist dosing).
   Mechanism: nitric oxide donor → smooth-muscle relaxation.
   Side effects: headache, hypotension, flushing.

3. Botulinum toxin (endoscopic injection to LES; pharmacologic procedure)
   Purpose: temporary chemical myotomy when surgery is not feasible.
   Mechanism: blocks acetylcholine at LES, reducing tone for months.
   Side effects: transient chest pain, reflux; benefit often wears off; repeatable.

4. Proton-pump inhibitors (PPIs: omeprazole, esomeprazole, lansoprazole)
   Purpose: treat reflux esophagitis and protect the esophagus post-procedures.
   Typical dose: omeprazole 0.7–1 mg/kg/day (max per guidelines).
   Mechanism: blocks gastric acid secretion.
   Side effects: abdominal pain, diarrhea/constipation; long-term use needs review.

5. H2-blockers (ranitidine alternatives where available, famotidine)
   Purpose: backup or adjunct acid suppression.
   Mechanism: H2 receptor blockade → lower acid.
   Side effects: headache, rare agitation.

6. Antiemetics (ondansetron as needed)
   Purpose: reduce vomiting during flares or peri-procedure.
   Mechanism: 5-HT3 antagonism.
   Side effects: constipation, rare QT prolongation.

7. Prokinetics for reflux clearance (e.g., erythromycin low-dose)
   Purpose: help gastric emptying (not effective for achalasia obstruction itself).
   Mechanism: motilin receptor agonism.
   Side effects: cramps, diarrhea; drug interactions.

8. Baclofen (GABA-B agonist)
   Purpose: decrease transient LES relaxations and reflux; help rumination.
   Mechanism: central action reduces reflux episodes.
   Side effects: drowsiness, weakness; taper to avoid withdrawal.

9. Inhaled bronchodilators / steroids (pulmonology-guided)
   Purpose: treat wheeze or airway inflammation after aspiration.
   Mechanism: smooth-muscle relaxation (SABA) / anti-inflammatory (ICS).
   Side effects: tremor (SABA), oral thrush (ICS—rinse mouth).

10. Antibiotics (when aspiration pneumonia occurs)
    Purpose: treat bacterial infection.
    Mechanism: pathogen-directed therapy.
    Side effects: drug-specific (diarrhea, allergy).

11. Levetiracetam (for seizures in microcephaly, if present)
    Purpose: control seizures.
    Mechanism: synaptic vesicle protein 2A modulation.
    Side effects: irritability, somnolence (neurology supervises).

12. Valproate (alternative antiseizure, when appropriate)
    Purpose: seizure control.
    Mechanism: increases GABA; multiple actions.
    Side effects: weight gain, liver toxicity risk; avoid in pregnancy—specialist only.

13. Glycopyrrolate (for severe drooling if aspiration risk)
    Purpose: reduce saliva pooling.
    Mechanism: anticholinergic.
    Side effects: dry mouth, constipation, urinary retention.

14. Laxatives (PEG 3350, lactulose) for constipation
    Purpose: prevent stool retention that worsens feeding and reflux.
    Mechanism: osmotic water retention in stool.
    Side effects: bloating, gas.

15. Analgesia post-procedure (acetaminophen/ibuprofen as advised)
    Purpose: comfort after dilation or myotomy.
    Mechanism: COX inhibition (ibuprofen) / central analgesia (acetaminophen).
    Side effects: stomach upset (ibuprofen); liver risk with overdose (acetaminophen).

(The choice and sequence of medicines are individualized. Many children move to procedural/surgical options for durable relief of achalasia.) PMC

---

Dietary “molecular” supplements

There is no supplement that cures AMS. Supplements are used to correct deficiencies, support growth, and reduce reflux/aspiration risk.

1. Vitamin D3 – typical 400–1000 IU/day in children unless higher dose prescribed for deficiency. Function/mechanism: bone and immune support; hormone-like regulation of calcium.

2. Iron – dose per ferritin/hemoglobin; often 2–6 mg/kg/day elemental iron if deficient. Mechanism: hemoglobin/myelin formation; improves energy.

3. Zinc – 5–20 mg/day depending on age/deficit. Mechanism: tissue repair, taste, appetite.

4. Omega-3 DHA/EPA – 250–500 mg/day DHA+EPA in children (diet-first). Mechanism: neuronal membrane fluidity; anti-inflammatory.

5. Folate – age-appropriate RDA or targeted therapy if deficient. Mechanism: DNA synthesis, neurodevelopment.

6. Vitamin B12 – oral or injection if low/at risk; supports myelin and cognition.

7. Thiamine (B1) – RDA or higher if malnutrition risk; supports carbohydrate metabolism and nerve function.

8. Calcium (with vitamin D) – if dietary intake is low and PPI used long term.

9. Probiotics (e.g., Lactobacillus rhamnosus GG) – may help antibiotic-associated diarrhea and gut balance; evidence for reflux is mixed.

10. Medium-chain triglyceride (MCT) oil or modular calorie boosters – add energy without large volume; useful in failure to thrive.

(Exact products and dosages should be set by the dietitian/physician based on labs and growth.)

Regenerative / stem-cell drugs

• There are currently no approved “immunity booster,” regenerative, or stem-cell drugs that treat AMS. Stem-cell or gene-therapy approaches for microcephaly or achalasia are experimental and not recommended outside ethically approved clinical trials.

• Safe and evidence-based ways to support immunity include: full routine vaccination, adequate sleep, corrected micronutrient deficiencies (vitamin D, iron, zinc), and good dental/airway hygiene.

• IVIG or other immune therapies are not routine for AMS; they are used only if a separate, proven immunodeficiency exists.

• Gene therapy: no clinical gene therapy is established for AMS today. Families can periodically check recognized clinical-trial registries with their clinicians.

(This caution protects you from ineffective or risky interventions and aligns with current rare-disease references that emphasize supportive care.) Genetic & Rare Diseases CenterNCBI

---

Procedures/surgeries

1. Endoscopic pneumatic dilation
   What: a balloon is placed across the lower esophageal sphincter and inflated to tear/stretch the tight muscle.
   Why: to improve food passage when medicines fail or as a bridge to surgery.
   Notes: effective but may need repeat; risk of perforation and reflux.

2. Heller myotomy (laparoscopic) with partial fundoplication
   What: surgeons cut the LES muscle fibers; a partial wrap is added to reduce reflux.
   Why: durable relief for many children/teens with achalasia.
   Notes: hospital stay is short; reflux control remains important.

3. POEM (Per-Oral Endoscopic Myotomy)
   What: endoscopic tunnel in esophageal wall to cut the LES internally.
   Why: less invasive alternative to surgical myotomy with similar efficacy in experienced centers.
   Notes: higher post-procedure reflux risk—plan acid suppression.

4. Botulinum toxin injection (endoscopic)
   What: chemical relaxation of LES by injecting botulinum toxin into the sphincter.
   Why: temporary option for frail patients or as a diagnostic/bridging measure.
   Notes: wears off in months; may complicate later surgery due to scarring.

5. Feeding tube (G-tube, sometimes with fundoplication)
   What: a tube to the stomach for direct feeding/meds; anti-reflux surgery may be added in selected cases.
   Why: severe aspiration risk or poor growth despite therapy.
   Notes: can be temporary or long-term; improves nutrition and lowers pneumonia risk.

(Choice depends on age, anatomy, local expertise, and family goals.) PMC

---

Prevention ideas

• Genetic counseling for families with a known case; discuss autosomal-recessive inheritance and risks in future pregnancies; consider carrier testing where available. PubMed

• Avoid consanguineous marriage to lower risk of recessive diseases in general. PubMed

• Prenatal/early postnatal monitoring in at-risk pregnancies (head growth, feeding readiness). Genetic & Rare Diseases Center

• Avoid possible harmful drug exposures in pregnancy (e.g., mefloquine case observation—discuss travel meds with obstetrics). Genetic & Rare Diseases CenterNCBI

• Early swallow assessment in infants with poor weight gain or coughing.

• Aspiration precautions at home and school (textures, posture, supervision).

• Routine immunizations (including influenza and pneumococcal per schedule).

• Dental care to reduce oral bacterial load.

• Safe sleep and reflux positioning per clinician advice.

• Sick-day plan for dehydration and aspiration risk.

---

When to see a doctor urgently

• Repeated choking, bluish lips, or trouble breathing

• Chest pain, persistent vomiting, or blood in vomit

• High fever with cough or fast breathing (possible pneumonia)

• Poor weight gain, dehydration (few wet diapers/urine)

• Seizures, loss of skills, or sudden behavior changes

• After a dilation/myotomy: severe chest pain, fever, inability to swallow liquids

---

What to eat and what to avoid

What to eat (as tolerated and advised by SLP/dietitian):

• Soft, moist foods: yogurt, porridge, soups, mashed vegetables, tender fish, soft rice, well-cooked lentils/khichuri, ripe bananas, stewed fruit

• Energy-dense add-ins: ghee/healthy oils in small amounts, nut/seed butters (if safe), powdered milk to porridge, MCT oil as prescribed

• Warm (not very hot) liquids sipped slowly; nutrient-rich shakes at approved thickness

• Small portions, many times a day; sip water between bites (if safe)

What to limit/avoid:

• Dry, crumbly, or sticky foods (plain bread, dry meats, chunky peanut butter)

• Very spicy, acidic, or fried meals that worsen reflux

• Very cold fizzy drinks, caffeine, and chocolate if they trigger symptoms

• Late large meals before bedtime

---

Frequently asked questions (FAQs)

1. Is there a cure for AMS?
   No specific cure exists yet. Care focuses on feeding safety, nutrition, development, and—when needed—procedures to open the LES.

2. Is AMS the same as Triple-A (Allgrove) syndrome?
   No. Triple-A includes achalasia, alacrima (no tears), and adrenal insufficiency. AMS links achalasia with microcephaly and intellectual disability. Some symptoms can overlap but they are distinct conditions. MedlinePlusGenetic & Rare Diseases Center

3. How rare is it?
   Extremely rare; only a few families are described in the literature and registries. orpha.netGenetic & Rare Diseases Center

4. How is achalasia diagnosed in a child?
   By symptoms plus tests such as barium swallow, endoscopy, and manometry (pressure study) showing a tight LES and poor peristalsis. PMC

5. Will surgery fix swallowing forever?
   Surgery (Heller or POEM) often gives long-term relief, but reflux may increase and some children need medicines or later touch-ups.

6. Can my child eat by mouth after treatment?
   Often yes, with SLP guidance. Some children need combined oral and tube feeding.

7. Does microcephaly always mean severe disability?
   Severity varies. Early therapies and supports help each child reach their best potential. Wikipedia

8. What about growth and weight?
   With a dietitian and safe feeding plan, most children can gain weight. A G-tube is an option if oral feeding is unsafe or too limited.

9. Are there special risks with anesthesia or procedures?
   Aspiration risk is higher. Teams take precautions (fasting rules, airway protection).

10. Are vaccines safe?
    Yes—routine vaccines are recommended unless your doctor has a specific reason to delay.

11. Could brothers or sisters be affected?
    If both parents are carriers (autosomal recessive), each pregnancy has a 25% chance to be affected. Genetic counseling can explain options. PubMed

12. What about school?
    Ask for an IEP and therapies (speech/OT/PT). AAC tools can support communication and learning.

13. Should we try “immune boosters” or stem-cell treatments found online?
    No approved or proven “booster” or stem-cell treatments exist for AMS. Discuss any trial only with your medical team. Genetic & Rare Diseases CenterNCBI

14. Can reflux medicines fix achalasia?
    They reduce acid damage and symptoms but do not open the tight LES. Mechanical treatments (dilation/myotomy/POEM) address the blockage. PMC

15. Where can we learn more or find support?

• GARD (NIH) page on Achalasia–Microcephaly

• Orphanet disease summary

• Discuss with your local rare-disease network/clinical geneticist. Genetic & Rare Diseases Centerorpha.net

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 01, 2025.

PDF Documents For This Disease Condition References